GB1518813A - Diagnostic agent - Google Patents

Diagnostic agent

Info

Publication number
GB1518813A
GB1518813A GB24287/75A GB2428775A GB1518813A GB 1518813 A GB1518813 A GB 1518813A GB 24287/75 A GB24287/75 A GB 24287/75A GB 2428775 A GB2428775 A GB 2428775A GB 1518813 A GB1518813 A GB 1518813A
Authority
GB
United Kingdom
Prior art keywords
june
blood plasma
water
intravascularly
diagnostic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24287/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of GB1518813A publication Critical patent/GB1518813A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB24287/75A 1974-06-06 1975-06-05 Diagnostic agent Expired GB1518813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
GB1518813A true GB1518813A (en) 1978-07-26

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24287/75A Expired GB1518813A (en) 1974-06-06 1975-06-05 Diagnostic agent

Country Status (8)

Country Link
JP (1) JPS517113A (cg-RX-API-DMAC7.html)
AU (1) AU8164675A (cg-RX-API-DMAC7.html)
CA (1) CA1039274A (cg-RX-API-DMAC7.html)
DE (1) DE2524278A1 (cg-RX-API-DMAC7.html)
FR (1) FR2273516A1 (cg-RX-API-DMAC7.html)
GB (1) GB1518813A (cg-RX-API-DMAC7.html)
NL (1) NL7506743A (cg-RX-API-DMAC7.html)
SE (1) SE420566B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Also Published As

Publication number Publication date
NL7506743A (nl) 1975-12-09
AU8164675A (en) 1976-12-02
FR2273516B1 (cg-RX-API-DMAC7.html) 1979-01-05
FR2273516A1 (fr) 1976-01-02
SE7407461L (sv) 1975-12-08
SE420566B (sv) 1981-10-19
CA1039274A (en) 1978-09-26
JPS517113A (cg-RX-API-DMAC7.html) 1976-01-21
DE2524278A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
EP0787017B2 (en) Diagnostic preparation for detection of helicobacter pylori
US5811388A (en) Delivery of drugs to the lower GI tract
CA1165686A (en) Radioactive diagnostic agent and non-radioactive carrier therefor
US4071613A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
JPS517113A (cg-RX-API-DMAC7.html)
CA1105815A (en) Red blood cell labelling kit
Schilsky et al. Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion
EP0063946A1 (en) Diagnosis of kidney function
DE69001000T2 (de) Radioaktives diagnosemittel.
Wingårdh et al. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy
US4057618A (en) Radioiodinated bleomycin
CN111377968B (zh) 一类含芳基硼酸的99mTc(Ⅲ)配合物及其药盒配方和应用
JPS5842846B2 (ja) 肝臓および骨髄走査用テクネチウム−９９ｍ標識放射線診断剤とその製造法
Balaban et al. Effect of the radiolabel mediator tropolone on lymphocyte structure and function
Hudson et al. Tumour uptake of thallium-201 chloride
Glover et al. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
JPS63170400A (ja) 放射性医薬品とその調製用高分子化合物
Järnerot et al. Olsalazine does not increase the bile acid losses in subjects with a permanent ileostomy
Shaeffer Lack of enhanced lysis of fibrinogen-I131 by anticoagulants in tumor-bearing rats
JPS60126231A (ja) 放射性診断剤
UA6779A (uk) Спосіб визначення функціонального стану системи кровотворення
Balachandran et al. Tissue Distribution of 14C-, 125I-, and 131I-Diphenylhydantoin in the Toadfish, Rat, and Human with Insulinomas
King et al. Laboratory methods for screening possible inhibitors of dental caries
Chatterjee Debnath et al. Technetium-99m cysteine; a novel radiopharmaceutical for detection of experimental myocardial infarction in rats

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee